Co-crystal structure of sars-cov-2 mpro c145a with substrate peptide 8/9 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M.
Date: 2021-12-20 Method: X-RAY DIFFRACTION Resolution: 2.18 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 7T9Y_A , 7T9Y_B , 7T9Y_C , 7T9Y_D
Co-crystal structure of sars-cov-2 mpro c145a with substrate peptide 9/10 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M.
Date: 2021-12-20 Method: X-RAY DIFFRACTION Resolution: 1.78 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 7TA4_A , 7TA4_B , 7TA4_C , 7TA4_D
Co-crystal structure of sars-cov-2 mpro c145a with substrate peptide 10/11 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M.
Date: 2021-12-20 Method: X-RAY DIFFRACTION Resolution: 2.28 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 7TA7_A , 7TA7_B , 7TA7_C , 7TA7_D
Co-crystal structure of sars-cov-2 mpro c145a with substrate peptide 12/13 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M.
Date: 2021-12-21 Method: X-RAY DIFFRACTION Resolution: 1.8 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 7TB2_A , 7TB2_B
Co-crystal structure of sars-cov-2 mpro c145a with substrate peptide 13/14 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M.
Date: 2021-12-22 Method: X-RAY DIFFRACTION Resolution: 2.45 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 7TBT_A , 7TBT_B
Co-crystal structure of sars-cov-2 mpro c145a with substrate peptide 15/16 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M.
Date: 2021-12-22 Method: X-RAY DIFFRACTION Resolution: 1.94 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct Sequences Data: 7TC4_A , 7TC4_B , 7TC4_C , 7TC4_D
Crystal structure of sars cov-2 mpro with pfizer intravenous inhibitor pf-00835231 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M.
Date: 2022-07-22 Method: X-RAY DIFFRACTION Resolution: 1.86 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 8DSU_A , 8DSU_B
Crystal structure of sars cov-2 mpro mutant l141r with pfizer intravenous inhibitor pf-00835231 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M.
Date: 2022-07-25 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 8DT9_A , 8DT9_B
Crystal structure of sars cov-2 mpro mutant n142p with pfizer intravenous inhibitor pf-00835231 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M.
Date: 2022-08-19 Method: X-RAY DIFFRACTION Resolution: 2.75 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 8E4W_A , 8E4W_B
Crystal structure of sars cov-2 mpro mutant l50f with nirmatrelvir captured in two conformational states Deposition Author(s): Schiffer, C.A. , Shaqra, A.M.
Date: 2022-08-20 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 8E5C_A